Kentucky · 2025 Regular Session · Bill
SB 14: AN ACT relating to pharmaceutical manufacturers.
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 14 is a bill introduced in the Kentucky Senate on January 7, 2025. According to its official title, it concerns: AN ACT relating to pharmaceutical manufacturers. Most recent recorded action (February 14, 2025): to Committee on Committees (H).
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| No sponsor recorded in source data. | ||||
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- to Committee on Committees (H)
- received in House
- passed 33-4
- floor amendments (2) and (1-title) withdrawn
- 3rd reading
- posted for passage in the Regular Orders of the Day for Thursday, February 13, 2025
- floor amendments (1-title) and (2) filed
- 2nd reading, to Rules
- reported favorably, 1st reading, to Calendar
- to Health Services (S)
- to Committee on Committees (S)
- introduced in Senate